Stay updated on Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.

Latest updates to the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded a Related Topics section with links to Multiple myeloma and MedlinePlus Genetics to provide background information.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check41 days agoChange DetectedRemoved mentions of 'Multiple myeloma' and related topics such as MedlinePlus Genetics from the page.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2; this does not affect study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded 'Multiple myeloma' and related topics such as MedlinePlus Genetics; updated the page revision to v3.4.1. Removed the government funding notice about operating status and the prior revision note v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.